Search
Returning search results with filters:
Remove filter for
Category: Health product
Remove filter for
Issue: COVID
Clear all
Type
Audience
Category
Issue
Last updated
Please note: using the search filters may not provide accurate search results for records prior to November 2021. When searching for older records, please ensure that you use the include archive checkbox.
Displaying 1 - 8 of 8 items.
… Last updated 2021-11-09 Summary Product Janssen and Vaxzevria (AstraZeneca) COVID-19 vaccines Issue Health products - … following symptoms after vaccination with the Janssen and Vaxzevria COVID-19 vaccines: unexplained bleeding, …
AlertPublic advisory | 2021-11-09
… (CLS) have been reported following vaccination with AstraZeneca COVID-19 Vaccine. A history of CLS was noted in … affected AstraZeneca COVID-19 Vaccine, COVID-19 Vaccine (ChAdOx1-S [recombinant]) 5 mL solution for intramuscular … AstraZeneca Canada Inc. COVISHIELD, COVID-19 Vaccine (ChAdOx1-S [recombinant]) 5 mL solution for intramuscular …
AlertHealth professional risk communication | 2021-06-29
… been observed very rarely following vaccination with the AstraZeneca COVID-19 Vaccine. Health Canada has assessed the … affected AstraZeneca COVID-19 Vaccine, COVID-19 Vaccine (ChAdOx1-S [recombinant]) 5 mL solution for intramuscular … AstraZeneca Canada Inc. COVISHIELD, COVID-19 Vaccine (ChAdOx1-S [recombinant]) 5 mL solution for intramuscular …
AlertHealth professional risk communication | 2021-03-24
… COVISHIELD (manufactured by Serum Institute of India) and AstraZeneca COVID-19 VACCINE (manufactured by AstraZeneca) are ChAdOx1-S recombinant vaccines developed by AstraZeneca and … section). Products affected COVISHIELD, COVID-19 Vaccine (ChAdOx1-S [recombinant]) 5 mL solution for intramuscular …
AlertHealth professional risk communication | 2021-03-01
… information during the initial distribution of the AstraZeneca COVID-19 Vaccine. Audiences Healthcare … and healthcare professionals at identified points of use. AstraZeneca Canada Inc. (AstraZeneca) (the Canadian importer … affected AstraZeneca COVID-19 Vaccine, COVID-19 Vaccine (ChAdOx1-S [recombinant]), 5 mL solution for intramuscular …
AlertHealth professional risk communication | 2021-03-01
… information during the initial distribution of the AstraZeneca COVID-19 Vaccine (US-labelled vaccine supplies) … and healthcare professionals at identified points of use. AstraZeneca Canada Inc. (AstraZeneca) (the Canadian importer … and Supplier in Canada AstraZeneca COVID-19 Vaccine, (ChAdOx1-S [recombinant]) Suspension for Intramuscular …
AlertHealth professional risk communication | 2021-03-31
… number: RA-75389 Last updated: 2021-06-29 Summary Product: AstraZeneca and COVISHIELD COVID-19 vaccines Issue: Health … is updating the product monographâor labelâfor the AstraZeneca and COVISHIELD COVID-19 vaccines to add capillary … with a history of capillary leak syndrome to not get the AstraZeneca or COVISHIELD COVID-19 vaccine. The label has …
AlertPublic advisory | 2021-06-29
… adverse events in Europe following immunization with the AstraZeneca COVID-19 vaccine, and would like to reassure … these events. To date, no adverse events related to the AstraZeneca COVID-19 vaccine, or the version manufactured by … temporarily paused the use of specific batches of the AstraZeneca vaccine or use of the AstraZeneca vaccine …
AlertPublic advisory | 2021-03-11